A Case of New-onset Immune-mediated Necrotizing Myopathy and Trigeminal Neuropathy after SARS-CoV-2 mRNA Vaccination in a Patient with Rheumatoid Arthritis and Sjögren's Syndrome

Takuma Tsuzuki Wada; Kazuhiro Yokota; Fumito Inayoshi; Sakon Sakai; Nobuhito Okumura; Mayumi Matsuda; Iichiro Osawa; Yasuto Araki; Yu Funakubo Asanuma; Yuji Akiyama; Toshihide Mimura

doi:10.2169/internalmedicine.2551-23

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

A Case of New-onset Immune-mediated Necrotizing Myopathy and Trigeminal Neuropathy after SARS-CoV-2 mRNA Vaccination in a Patient with Rheumatoid Arthritis and Sjögren's Syndrome

Takuma Tsuzuki Wada, Kazuhiro Yokota, Fumito Inayoshi, Sakon Sakai, Nobuhito Okumura, Mayumi Matsuda, Iichiro Osawa, Yasuto Araki, Yu Funakubo Asanuma, Yuji Akiyama, Toshihide Mimura

著者情報

Takuma Tsuzuki Wada
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Kazuhiro Yokota
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Fumito Inayoshi
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Sakon Sakai
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Nobuhito Okumura
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Mayumi Matsuda
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Iichiro Osawa
Department of Radiology, Saitama Medical University Hospital, Japan
Yasuto Araki
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Yu Funakubo Asanuma
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Yuji Akiyama
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan
Toshihide Mimura
Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan

キーワード: SARS-CoV-2 mRNA vaccine, immune-mediated necrotizing myopathy, trigeminal neuropathy, rheumatoid arthritis, Sjögren's syndrome

ジャーナルオープンアクセス早期公開

論文ID: 2551-23

DOI https://doi.org/10.2169/internalmedicine.2551-23

この記事には本公開記事があります。

The final version of this article is now available: Vol. 62 (2023), No. 24 pp. 3699-3706

詳細

抄録

We present the case of a 42-year-old woman with rheumatoid arthritis and Sjögren's syndrome treated with adalimumab who developed immune-mediated necrotizing myopathy (IMNM) and trigeminal neuropathy after SARS-CoV-2 mRNA vaccination. Trigeminal neuralgia and elevated serum creatine kinase levels emerged 12 days post-vaccination, followed by myalgia in the femoral muscles. IMNM was histologically diagnosed. The pathogenesis may involve molecular mimicry between the SARS-CoV-2 spike glycoprotein and autologous tissues triggered by vaccination. This case emphasizes the association between SARS-CoV-2 vaccination, tumor necrosis factor inhibitor, IMNM, and trigeminal neuropathy, as well as the importance of monitoring immune-mediated adverse events following SARS-CoV-2 vaccination in patients with autoimmune disease.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）